Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Sleep Disorders Research

---
identifier: "/us/fr/02-17101"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Sleep Disorders Research"
title_number: 0
title_name: "Federal Register"
section_number: "02-17101"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Sleep Disorders Research"
positive_law: false
currency: "2002-07-08"
last_updated: "2002-07-08"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "02-17101"
document_type: "notice"
publication_date: "2002-07-08"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "67 FR 45123"
fr_volume: 67
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Sleep Disorders Research

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Public Law 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

*Name:* Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Sleep Disorders Research.

*Times and Dates:* 2:00 p.m.-2:30 p.m., July 23, 2002 (Open); 2:40 p.m.-4:00 p.m., July 23, 2002 (Closed).

*Place:* Teleconference number (513) 841-4560.

*Status:* Portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters to be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to a FY02 Congressional appropriation.

*Contact Person for More Information:* Kathleen Goedel, National Institute for Occupational Safety and Health, CDC, 4676 Columbia Parkway Cincinnati, OH., telephone (513) 841-4560.

The Director, Management Analysis and Services Office has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: July 2, 2002.

Joe Salter,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).